BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20251024T030026EDT-16756hKX5z@132.216.98.100
DTSTAMP:20251024T070026Z
DESCRIPTION:JOINT CORE/EBOH EPI Seminar Series Fall 2025\n\nThe Seminars in
  Epidemiology organized by the Department of Epidemiology\, Biostatistics 
 and Occupational Health at the 海角精品黑料 School of Population and Global Heal
 th is a self-approved Group Learning Activity (Section 1) as defined by th
 e maintenance of certification program of the Royal College of Physicians 
 and Surgeons of Canada. Physicians requiring accreditation\, please comple
 te the Evaluation Formand send to admincoord.eboh [at] mcgill.ca ()\n	聽\n\n
 Patrick R. Lawler\, MD\, MPH\, FRCPC\n\nClinician-Scientist and Associate 
 Professor|\n	海角精品黑料 and University of Toronto\n\nWHEN: Monday\, 
 October 27\, 2025\, from 3:30-4:30pm\n	WHERE: Hybrid | 2001 海角精品黑料 College\
 , Rm 1140 &\n	Onsite at 5252 boul. de Maisonneuve - 3rd floor\, 3B Kitchen 
 | Zoom\n	**Note: Patrick Lawler will be presenting in-person at CORE\n	聽\n\n
 Speaker Bio\n\nDr. Patrick Lawler is director of the Cardiac Intensive Car
 e Unit at the 海角精品黑料 Health Centre in Montreal\, and also a sta
 ff cardiologist at Toronto General Hospital in Toronto\, both in Canada. H
 e is an Associate Professor of Medicine at 海角精品黑料 and the Unive
 rsity of Toronto. His research employs Bayesian adaptive platform randomiz
 ed clinical trials\, clinical epidemiology\, and translational methods. He
  has a focus on methods to identify heterogeneity of treatment effect in c
 linical trials. He has led randomized clinical trials in acutely/criticall
 y ill patients\, and has also supported the design and implementation of o
 thers. His research has been funded by greater than $35M from the Canadian
  Institutes of Health Research\, the U.S. National Institutes of Health\, 
 philanthropy\, and others\, and has been published in the New England Jour
 nal of Medicine\, JAMA\, the European Heart Journal\, Circulation\, Intens
 ive Care Medicine\, Critical Care Medicine\, and elsewhere. He is the chie
 f medical officer at Sparked Inc.\, an early-stage Toronto-based microflui
 dic diagnostic company. He serves on executive committees for the American
  Heart Association and as the inaugural associate editor for cardiac criti
 cal care for the American College of Cardiology's open access journal JACC
 : Advances.\n	\n	Learning Objectives\n\nAt the completion of this talk\, att
 endees will be able to:\n\n\n	Understand heterogeneous treatment effects in
  randomized controlled trials and their clinical implications\;\n	Develop f
 amiliarity with modern statistical methods to identify differential treatm
 ent responses across patient subgroups in clinical trials including the es
 timation of individualized treatment effects\;\n	Consider emerging clinical
  trial designs built around these frameworks. 聽\n\n\n聽\n\n聽\n
DTSTART:20251027T193000Z
DTEND:20251027T203000Z
SUMMARY:Estimating treatment effects for individual patients using randomiz
 ed controlled trials: Promise and challenges
URL:/epi-biostat-occh/channels/event/estimating-treatm
 ent-effects-individual-patients-using-randomized-controlled-trials-promise
 -and-368484
END:VEVENT
END:VCALENDAR